Skip to main content
. 2023 Aug 2;13:1230934. doi: 10.3389/fonc.2023.1230934

Table 5.

Mitochondria Disorders – TCA Cycle.

Enzymes Role Disease Name Upregulated Cancers Downregulated Cancers
Citrate synthase (CS) Binds with the oxaloacetate and reacts with acetyl-CoA, leading to the production of citrate. Ovarian (226), pancreas (227), and colon (228). Cervical (229).
Aconitase (ACO2) Catalyzes the conversion of citrate into isocitrate Cerebellar-retinal degeneration (230, 231) and with severe optic atrophy and spastic paraplegia (232). HCC (233). Gastric cancer (234) and colorectal cancer (235).
Isocitrate dehydrogenase (IDH). Three IDH isoforms exist IDH1, IDH2, and IDH3. Converts of isocitrate into α-ketoglutarate (α-KG) IDH1 and IDH2 in glioblastoma (236) IDH2 in colorectal (237) and lung (238). IDH3-a in glioblastoma (239) and in HCC (240).
α-ketoglutarate dehydrogenase (α-KGDH), also called 2-oxoglutarate dehydrogenase (OGDH). Converts α-KG into succinyl-CoA alpha-ketoglutarate dehydrogenase complex (KGDHC) deficiency Gastric (241).
Succinyl-CoA synthetase (SCS), also known as Succinyl-CoA ligase.
SCS is composed of two subunits, an α-subunit which is encoded by the gene SUCLG1, and the β-subunit which is encoded by the gene SUCLA2 (specificity for ADP), or by the gene SUCLG2 (specificity for GDP).
Breaks down succinyl-CoA into succinate and free CoA, and converts ADP or GDP into ATP or GTP, respectively. Succinyl-CoA ligase deficiency SUCLG1 in acute myeloid leukemia (242). SUCLA2 in prostate (243).
Succinate dehydrogenase (SDH), also known as Succinate-coenzyme Q reductase (SQR). SDH is composed of four subunits, SDHA, SDHB, SDHC and SDHD. Catalyzes the oxidation of succinate to fumarate and transfers electrons from succinate to ubiquinone (coenzyme Q). Succinate dehydrogenase (SDH) deficiency SDHB in ovarian (244).
Fumarase, also known as fumarate hydratase Catalyzes the hydration of fumarate into L-malate. Fumarase deficiency, also known as Fumarate hydratase deficiency or Fumaric aciduria. Clear cell renal carcinomas (245).
Malate dehydrogenase (MDH2) Catalyzes the reversible conversion of malate into oxaloacetate Mitochondrial malate dehydrogenase (MDH2) deficiency Prostate (246).